Beyond the CNS, and in another diabetes-related disorder, GLP-1 receptor agonists have shown great promise in diabetic peripheral neuropathy (DPN), a common complication of diabetes marked by nerve damage caused by chronic hyperglycemia and oxidative stress
Several studies have examined the effectiveness of supplemental carnitine in the management of cardiac ischemia (restriction of blood flow to the heart) and peripheral arterial disease (whose most important symptom is poor circulation in the legs, known as intermittent claudication)
The Medicare and Medicaid Problem The biggest problem was that Medicare didn't cover medications made specifically for weight loss
Novos GLP-1 franchise has dominated to date, being first to market with a weight-loss GLP-1
Dietary interventions for recurrent abdominal pain in childhood
Semaglutide the active ingredient in Ozempic and Wegovy mimics GLP-1, a hormone your body naturally releases after you eat